Save
7 Steps
Maximum: 4 CME cr.
Sign in to view your progression
Program Overview
Learning Objectives
Target Audience
Credit Designation
Disclosure/Disclaimer

This course will provide an overview of different types of acquired thrombocytopenia.

Participants will gain basic knowledge of platelet production and the mechanisms of thrombocytopenia;

Participants will gain an understanding of the pathogenesis of acquired thrombocytopenias and be able to establish a differential diagnosis;

Participants will gain an understanding of key concepts in the clinical and laboratory diagnosis of ITP, DITP and HIT;

Participants will gain an understanding of key concepts in the management of ITP, DITP and HIT.

This activity is intended for physicians involved in the diagnosis and management of patients who have a low platelet count. The activity will help clinicians gain familiarity with the pathogenesis of acquired thrombocytopenias and be able to establish a differential diagnosis.

Thrombocytopenia is among the most common reason for consultation with a hematologist for both in-patients and out-patients.  There are different disorders which can cause a low platelet count and put a patient at risk for bleeding. The course will help clinicians to understand the differences among the different underlying disorders and how to appropriately manage impacted patients.

ACCME Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The Medical College of Wisconsin and International Society on Thrombosis and Haemostasis. The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.

AMA Credit Designation Statement:

The Medical College of Wisconsin designates this Enduring material for a maximum of 4 AMA PRA Category 1 Credit(s) ™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All persons in control of the content of the course have no relevant financial disclosures except:

Module 1

Tamam Bakchoul disclosed relationships with Aspen GMbH Germany, CSL-Behring and Hämostase Update as a speaker.

Module 2

Donald Arnold has disclosed relationships with Novartis and Amgen as a researcher and with Novartis, Amgen, UCB and Rigel as a consultant.

Siraj Mithoowani disclosed a relationship with Pfizer as an educational support recipient.

Cindy Neunert disclosed a relationship with Sanofi-Genzyme as a consultant.

Module 3

Yves Gruel disclosed a relationship with Aspen as a speaker and LFB as a consultant.

François Mullier disclosed relationships with Stago, Werfen, Nodia, Sysmex and Bayer as a recipient of research support. He also disclosed relationships with Boehringer Ingelheim, Bayer Healthcare, Bristol Myers Squibb and Pfizer as a speaker.

Claire Pouplard disclosed a relationship with Stago as a contractor.

Module 4

Tamam Bakchoul disclosed relationships with Aspen GMbH Germany, CSL-Behring and Hämostase Update as a speaker.

Brian Curtis disclosed a relationship with Ionis Pharmaceuticals as an advisory board member. 

In accordance with the ACCME® standards for Commercial Support Number 6, these relationships were reviewed via the MCW conflict of interest resolution process and resolved.

This course was partially supported by an educational grant from Dova Pharmaceuticals.

 

Personal Information form - mandatory to receive CME
Please login here or create an account to view this content.
Pre-Test
Module 1: Mechanisms of Platelet Production and Destruction
Module 2: Primary Immune Thrombocytopenia
Module 3: Heparin-Induced Thrombocytopenia
Module 4: Drug-Induced Thrombocytopenia
Post-Test, Evaluation & Certificate
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings